Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Lung Water in COPD at Altitude
NCT03540901Phase 4Completed
- Sponsor
- University of Zurich
- Start
- May 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in high altitude pulmonary edema (HAPE), sponsored by University of Zurich. Started May 2018; status: completed.
02
Drugs
acetazolamide
03
Conditions
high altitude pulmonary edema (HAPE)
Beyond the preview
Go deeper on NCT03540901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540901.